EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.790
https://www.valueinhealthjournal.com/article/S1098-3015(25)03347-9/fulltext
Title :
EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03347-9&doi=10.1016/j.jval.2025.09.790
First page :
Section Title :
Open access? :
No
Section Order :
10357